Search results
These Vibration Plates Boost Lymphatic Drainage & Gives You the Results of a 45-Minute Workout in 15...
The Daily Beast via Yahoo Style Singapore· 1 year agoScouted/The Daily Beast/Lifepro. Scouted selects products independently. If you purchase something...
Faro Technologies Inc (FARO) Q1 Earnings: Mixed Results Amidst Revenue Growth and Net Loss ...
GuruFocus.com via Yahoo Singapore Finance· 2 months agoRevenue: Reported at $84.2 million, slightly above the estimated $81.07 million, meeting analyst...
4D Molecular Therapeutics First Quarter 2024 Earnings: US$0.66 loss per share (vs US$0.88 loss in 1Q...
Simply Wall St. via Yahoo Singapore Finance· 2 months ago4D Molecular Therapeutics (NASDAQ:FDMT) First Quarter 2024 Results Key Financial Results Revenue:...
Faro Technologies Inc (FARO) Reports Mixed 2023 Financial Results with Strong Cash Flow Performance
GuruFocus.com via Yahoo Singapore Finance· 4 months agoQ4 Revenue: $98.8 million, a 5% decrease year over year. Full Year Revenue: $358.8 million, a 4%...
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Consensus Forecasts Have Become A Little Darker Since...
Simply Wall St. via Yahoo Singapore Finance· 4 months agoInvestors in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) had a good week, as its shares rose 8.0%...
4D Molecular Therapeutics, Inc. (FDMT) Reports Q4 Loss, Lags Revenue Estimates
Zacks via Yahoo Singapore Finance· 1 year ago4D Molecular Therapeutics, Inc. (FDMT) delivered earnings and revenue surprises of -12% and 74.90%,...
All You Need to Know About 4D Molecular Therapeutics, Inc. (FDMT) Rating Upgrade to Strong Buy
Zacks via Yahoo Singapore Finance· 5 months ago4D Molecular Therapeutics, Inc. (FDMT) might move higher on growing optimism about its earnings...
4D Molecular Therapeutics, Inc. (FDMT) May Report Negative Earnings: Know the Trend Ahead of Q1...
Zacks via Yahoo Singapore Finance· 2 months ago4D Molecular Therapeutics (FDMT) doesn't possess the right combination of the two key ingredients...
4D Molecular Therapeutics Inc (FDMT) Q1 2024 Earnings: Misses Analyst Net Income Projections
GuruFocus.com via Yahoo Singapore Finance· 2 months agoRevenue: Reported at $0.028 million, significantly below the estimated $0.79 million. Net Loss: Totaled $32.4 million, above the estimated net loss of $35.81 million. Earnings Per Share (EPS ...
4D Molecular soars as mid-stage data for eye disease therapy 'checks all boxes'
Reuters via Yahoo Singapore Finance· 5 months agoShares of 4D Molecular Therapeutics more than doubled on Monday after the therapy developer reported results from a mid-stage trial of its eye disease therapy. The stock hit an over two-year ...